Silence Therapeutics (SLN) Operating Expenses: 2020-2025
Historic Operating Expenses for Silence Therapeutics (SLN) over the last 6 years, with Sep 2025 value amounting to $26.3 million.
- Silence Therapeutics' Operating Expenses fell 5.45% to $26.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $57.5 million, marking a year-over-year increase of 204.30%. This contributed to the annual value of -$18.9 million for FY2024, which is 69.70% down from last year.
- Latest data reveals that Silence Therapeutics reported Operating Expenses of $26.3 million as of Q3 2025, which was up 679.03% from $3.4 million recorded in Q2 2025.
- Silence Therapeutics' Operating Expenses' 5-year high stood at $143.1 million during Q4 2023, with a 5-year trough of -$15.5 billion in Q1 2021.
- For the 3-year period, Silence Therapeutics' Operating Expenses averaged around $14.4 million, with its median value being $121,000 (2025).
- Per our database at Business Quant, Silence Therapeutics' Operating Expenses tumbled by 99.58% in 2021 and then soared by 258.32% in 2024.
- Silence Therapeutics' Operating Expenses (MRQ) stood at $119.9 million in 2021, then decreased by 3.54% to $115.6 million in 2022, then grew by 23.76% to $143.1 million in 2023, then plummeted by 80.70% to $27.6 million in 2024, then fell by 4.63% to $26.3 million in 2025.
- Its last three reported values are $26.3 million in Q3 2025, $3.4 million for Q2 2025, and $121,000 during Q1 2025.